These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28144253)

  • 1. PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.
    Banach M; Jankowski P; Jóźwiak J; Cybulska B; Windak A; Guzik T; Mamcarz A; Broncel M; Tomasik T; Rysz J; Jankowska-Zduńczyk A; Hoffman P; Mastalerz-Migas A
    Arch Med Sci; 2017 Feb; 13(1):1-45. PubMed ID: 28144253
    [No Abstract]   [Full Text] [Related]  

  • 2. PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.
    Banach M; Burchardt P; Chlebus K; Dobrowolski P; Dudek D; Dyrbuś K; Gąsior M; Jankowski P; Jóźwiak J; Kłosiewicz-Latoszek L; Kowalska I; Małecki M; Prejbisz A; Rakowski M; Rysz J; Solnica B; Sitkiewicz D; Sygitowicz G; Sypniewska G; Tomasik T; Windak A; Zozulińska-Ziółkiewicz D; Cybulska B
    Arch Med Sci; 2021; 17(6):1447-1547. PubMed ID: 34900032
    [No Abstract]   [Full Text] [Related]  

  • 3. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    ; Reiner Z; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D;
    Eur Heart J; 2011 Jul; 32(14):1769-818. PubMed ID: 21712404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of dyslipidaemias -  present and future. Guidelines of the Angiology Section of the Slovak Medical Chamber (2013)].
    Gavornik P; Dukát A; Gašpar L;
    Vnitr Lek; 2013 Oct; 59(10):932-8. PubMed ID: 24164369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can genetic testing help in the management of dyslipidaemias?
    Lazarte J; Hegele RA
    Curr Opin Lipidol; 2020 Aug; 31(4):187-193. PubMed ID: 32520779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).
    ; Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
    Atherosclerosis; 2016 Oct; 253():281-344. PubMed ID: 27594540
    [No Abstract]   [Full Text] [Related]  

  • 7. [Update Dyslipidaemias - Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias].
    Sinning D; Landmesser U
    Dtsch Med Wochenschr; 2017 Jun; 142(11):816-820. PubMed ID: 28564733
    [No Abstract]   [Full Text] [Related]  

  • 8. Lateral gene transfer of family A DNA polymerases between thermophilic viruses, aquificae, and apicomplexa.
    Schoenfeld TW; Murugapiran SK; Dodsworth JA; Floyd S; Lodes M; Mead DA; Hedlund BP
    Mol Biol Evol; 2013 Jul; 30(7):1653-64. PubMed ID: 23608703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician behaviors to promote informed decisions for prostate cancer screening: a National Research Network study.
    Linder SK; Kallen MA; Mullen PD; Galliher JM; Swank PR; Chan EC; Volk RJ
    J Cancer Educ; 2014 Jun; 29(2):345-9. PubMed ID: 24488590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels.
    Sosnowska B; Stepinska J; Mitkowski P; Bielecka-Dabrowa A; Bobrowska B; Budzianowski J; Burchardt P; Chlebus K; Dobrowolski P; Gasior M; Jankowski P; Kubica J; Mickiewicz A; Mysliwiec M; Osadnik T; Prejbisz A; Rajtar-Salwa R; Wita K; Witkowski A; Gil R; Banach M
    Arch Med Sci; 2024; 20(1):8-27. PubMed ID: 38414479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman M; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ;
    Atherosclerosis; 2011 Jul; 217(1):3-46. PubMed ID: 21882396
    [No Abstract]   [Full Text] [Related]  

  • 12. Family A DNA Polymerase Phylogeny Uncovers Diversity and Replication Gene Organization in the Virioplankton.
    Nasko DJ; Chopyk J; Sakowski EG; Ferrell BD; Polson SW; Wommack KE
    Front Microbiol; 2018; 9():3053. PubMed ID: 30619142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45-64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors.
    Luksiene D; Tamosiunas A; Baceviciene M; Radisauskas R; Malinauskiene V; Peasey A; Bobak M
    PLoS One; 2014; 9(6):e100158. PubMed ID: 24955583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    ; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D;
    Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445
    [No Abstract]   [Full Text] [Related]  

  • 15. US cost-effectiveness analysis of polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma.
    Matasar M; Masaquel A; S Ho R; Launonen A; Ng CD; Wang R; Fox D; Hossain F; Li J; Burke JM
    J Med Econ; 2023; 26(1):1134-1144. PubMed ID: 37674384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidaemias in women using hormonal contraceptives: a cross sectional study in Mulago Hospital Family Planning Clinic, Kampala, Uganda.
    Bakesiima R; Byakika-Kibwika P; Tumwine JK; Kalyango JN; Nabaasa G; Najjingo I; Nabaggala GS; Olweny F; Karamagi C
    BMJ Open; 2018 Oct; 8(10):e022338. PubMed ID: 30341126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996-2007.
    Ferrières J; Bongard V; Dallongeville J; Arveiler D; Cottel D; Haas B; Wagner A; Amouyel P; Ruidavets JB
    Arch Cardiovasc Dis; 2009 Apr; 102(4):293-301. PubMed ID: 19427606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and Treatment of Dyslipidaemias in Athletes.
    Christou GA; Kouidi EJ; Deligiannis AP; Kiortsis DN
    Curr Vasc Pharmacol; 2017; 15(3):238-247. PubMed ID: 28137212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation of Bacillus subtilis polA mutants by DNA polymerase I from Streptococcus pneumoniae.
    Martinez S; Lopez P; Espinosa M; Lacks SA
    Mol Gen Genet; 1987 Dec; 210(2):203-10. PubMed ID: 3125407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating science into guidance on the management of dyslipidaemias.
    De Backer GG
    Atherosclerosis; 2020 Dec; 315():145-147. PubMed ID: 33183742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.